Moleculin Biotech

MBRX

Börsenwert 8,43 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Vanguard Group Malvern, Pennsylvania	1,18 Mio. $	+245.595 $	+3	+25 %
2	2 Geode Capital Management Boston, Massachusetts	226.000 $	+81.865 $	+1	+50 %
3	3 Whitegate Investment Counselors Concord, New Hampshire	174.000 $	–	–	–
4	4 CIBC World Market Toronto, Ontario, Canada	170.000 $	+81.865 $	+1	+100 %
5	5 Truist Financial Charlotte, North Carolina	161.000 $	–	–	–
6	6 BlackRock New York	89.000 $	+81.865 $	+1	Neu
7	7 Bank of America Charlotte, North Carolina	45.000 $	–	–	–
8	8 Northern Trust Chicago, Illinois	41.000 $	+81.865 $	+1	Neu
9	9 Commonwealth Equity Services Waltham, Massachusetts	39.000 $	–	–	–
10	10 Laird Norton Wetherby Wealth Management San Francisco, California	35.000 $	–	–	–
11	11 Dimensional Fund Advisors Austin, Texas	31.000 $	–	–	–
12	12 Two Sigma Securities New York	24.000 $	–	–	–
13	13 Raymond James Financial Services Advisors St. Petersburg, Florida	23.000 $	–	–	–
14	14 Morgan Stanley New York	22.000 $	–	–	–
15	15 PNC Financial Services Group Pittsburgh, Pennsylvania	14.000 $	–	–	–
16	16 Centaurus Financial Anaheim, California	13.000 $	–	–	–
17	17 OneDigital Investment Advisors Overland Park, Kansas	5.000 $	–	–	–
18	APA 18 American Portfolios Advisors Holbrook, New York	2.685 $	–	–	–
19	19 Global Retirement Partners San Rafael, California	1.000 $	–	–	–
20	20 Archford Capital Strategies Swansea, Illinois	–	-6.000 $	–	–
21	21 Virtu Financial New York	–	-24.000 $	–	–
22	22 Wells Fargo San Francisco, California	–	-9.000 $	–	–

Moleculin Biotech MBRX Börsenwert 8,43 Mio. $

Moleculin Biotech

MBRX

Börsenwert 8,43 Mio. $